glp-1 receptor agonist atrial fibrillation risk Agonists in Heart Failure Frontiers | The potential of
Description
So, taking lower doses or titrating more slowly can help
The SURMOUNT and SURPASS trials put this head to head
Many people experience a two to four week period during the medication transition where weight loss stalls or they regain two to five pounds
[Updated 2024 Feb 11]
doi: 10.3390/ijms23179655
D.FlattP
